Azzouzi R - Search Results

1

Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer.

Roumier X, Azzouzi R, Valéri A, Guillemin F, Fournier G, Cussenot O, Mangin P, Cormier L. Roumier X, et al. Among authors: azzouzi r. Eur Urol. 2004 Mar;45(3):280-5; author reply 285-6. doi: 10.1016/j.eururo.2003.09.022. Eur Urol. 2004. PMID: 15036671

2

Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.

Cormier L, Valéri A, Azzouzi R, Fournier G, Cussenot O, Berthon P, Guillemin F, Mangin P. Cormier L, et al. Among authors: azzouzi r. Prostate. 2002 Jun 1;51(4):276-85. doi: 10.1002/pros.10092. Prostate. 2002. PMID: 11987156

3

Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.

Valeri A, Cormier L, Moineau MP, Cancel-Tassin G, Azzouzi R, Doucet L, Baschet F, Cussenot I, L'Her J, Berthon P, Mangin P, Cussenot O, Morin JF, Fournier G. Valeri A, et al. Among authors: azzouzi r. J Urol. 2002 Aug;168(2):483-7. doi: 10.1016/s0022-5347(05)64663-0. J Urol. 2002. PMID: 12131293

4

Early-onset hereditary prostate cancer is not associated with specific clinical and biological features.

Valeri A, Azzouzi R, Drelon E, Delannoy A, Mangin P, Fournier G, Berthon P, Cussenot O. Valeri A, et al. Among authors: azzouzi r. Prostate. 2000 Sep 15;45(1):66-71. doi: 10.1002/1097-0045(20000915)45:1<66::aid-pros8>3.0.co;2-w. Prostate. 2000. PMID: 10960844

5

High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy.

Valeri A, Fromont G, Sakr W, Azzouzi R, Dey J, Chantrel-Groussard K, Latil A, Berthon P, Cussenot O, Pontes JE, Cher ML. Valeri A, et al. Among authors: azzouzi r. Urol Oncol. 2005 Mar-Apr;23(2):87-92. doi: 10.1016/j.urolonc.2004.08.015. Urol Oncol. 2005. PMID: 15869992

6

[Epidemiology of familial prostatic cancer: 4-year assessment of French studies].

Valeri A, Drelon E, Azzouzi R, Delannoy A, Teillac P, Fournier G, Mangin P, Berthon P, Cussenot O. Valeri A, et al. Among authors: azzouzi r. Prog Urol. 1999 Sep;9(4):672-9. Prog Urol. 1999. PMID: 10555220 French.

7

Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.

Valeri A, Briollais L, Azzouzi R, Fournier G, Mangin P, Berthon P, Cussenot O, Demenais F. Valeri A, et al. Among authors: azzouzi r. Ann Hum Genet. 2003 Mar;67(Pt 2):125-37. doi: 10.1046/j.1469-1809.2003.00022.x. Ann Hum Genet. 2003. PMID: 12675688

8

Urinary morbidity after 125I brachytherapy of the prostate.

Mallick S, Azzouzi R, Cormier L, Peiffert D, Mangin PH. Mallick S, et al. Among authors: azzouzi r. BJU Int. 2003 Oct;92(6):555-8. doi: 10.1046/j.1464-410x.2003.04430.x. BJU Int. 2003. PMID: 14511032

9

[Acute urinary complications after prostate iodine-125 brachytherapy: evaluation and risk factors].

Mallick S, Azzouzi R, Bey P, Cormier L, Moreau JL, Peiffert D, Mangin P. Mallick S, et al. Among authors: azzouzi r. Cancer Radiother. 2002 Apr;6(2):99-105. doi: 10.1016/s1278-3218(02)00149-x. Cancer Radiother. 2002. PMID: 12035487 French.

10

PGE2 and LTB4 tissue levels in benign and cancerous prostates.

Larré S, Tran N, Fan C, Hamadeh H, Champigneulles J, Azzouzi R, Cussenot O, Mangin P, Olivier JL. Larré S, et al. Among authors: azzouzi r. Prostaglandins Other Lipid Mediat. 2008 Dec;87(1-4):14-9. doi: 10.1016/j.prostaglandins.2008.05.001. Epub 2008 Jun 3. Prostaglandins Other Lipid Mediat. 2008. PMID: 18577464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters